title: Cerebellar Cladophialophora bantiana infection in a patient with marginal zone lymphoma treated with immunochemotherapy including rituximab.
authors.affiliation: Department of Haematology Department of Microbiology Department of Radiology, Queen's Hospital, Romford, Essex, UK. Claire.hemmaway@bhrhospitals.nhs.uk
authors.forename: Claire
authors.initials: C
authors.lastname: Hemmaway
authors.forename: Etienne
authors.initials: E
authors.lastname: Laverse
authors.forename: Meredydd
authors.initials: M
authors.lastname: Nicholas
authors.forename: Zoltan
authors.initials: Z
authors.lastname: Nagy
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D020314:Central Nervous System Fungal Infections / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D002526:Cerebellar Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D016867:Immunocompromised Host; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone